The federal government is considering reclassifying marijuana in global drug treaties. The Food and Drug Administration (FDA) has asked for public comment on the “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use” of marijuana and several other substances. The international status of marijuana means that those nations who have signed drug control treaties aren’t supposed to legalize the substance, but that didn’t stop Uruguay and Canada from becoming the first to do so.
The FDA’s associate commissioner for policy, Leslie Kux said these comments “will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs.”
She added: “WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs.”
WHO’s Expert Committee on Drug Dependence (ECDD) will be heading to Geneva next month for a meeting to consider a classification change for cannabis and other drugs. The ECDD is currently gathering “information on the legitimate use, harmful use, status of national control and potential impact of international control,” according to the United Nations body.